Spritam | Levetiracetam Tablet, For Suspension Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Spritam | Levetiracetam Tablet, For Suspension while breastfeeding. We will also discuss about common side effects and warnings associated with Spritam | Levetiracetam Tablet, For Suspension.

What is Spritam | Levetiracetam Tablet, For Suspension used for?


SPRITAM is indicated for adjunctive therapy in the treatment of: Partial onset seizures in patients with epilepsy 4 years of age and older weighing more than 20 kg (1.1) Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy (1.2) Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy (1.3) 1.1 Partial Onset Seizures SPRITAM is indicated as adjunctive therapy in the treatment of partial onset seizures in patients with epilepsy 4 years of age and older weighing more than 20 kg. 1.2 Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy SPRITAM is indicated as adjunctive therapy in the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy. 1.3 Primary Generalized Tonic-Clonic Seizures SPRITAM is indicated as adjunctive therapy in the treatment of primary generalized tonic‑clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.

I am currently breastfeeding and I want to know if using Spritam | Levetiracetam Tablet, For Suspension is safe for my kid? Does it have any effect on milk production?

Spritam | Levetiracetam Tablet, For Suspension safe for breastfeeding
As per our analysis Spritam | Levetiracetam Tablet, For Suspension contains only one ingredient and that is Levetiracetam. We have analyzed Levetiracetam and it seems to be safe to use Levetiracetam while breastfeeding, that means usage of Spritam | Levetiracetam Tablet, For Suspension shall be safe while breastfeeding. Below you can check more details of Levetiracetam usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Levetiracetam is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from SPRITAM, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Spritam | Levetiracetam Tablet, For Suspension Breastfeeding Analsys


Levetiracetam while Breastfeeding

Safe

CAS Number: 102767-28-2

Piracetam analog with nootropic and anti-epileptic effect. Authorized for use in children in Europe. Excreted into breast milk but infant serum levels were shown to be low. No other side effect than one case of hypotonia in a 7 days old premature whose mother was also on anti-epileptic medication. Seizures along with neonatal abstinence syndrome in a botlle fed neonate whose mother had taken Levetiracetam and Phenobarbital in pregnancy ocurred. Symptoms disappeared after initiation of breastfeeding.

Spritam | Levetiracetam Tablet, For Suspension Breastfeeding Analsys - 2


Levetiracetam while Breastfeeding

CAS Number: 102767-28-2

Maternal doses of levetiracetam up to 3500 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. If levetiracetam is required by the mother, it is not a reason to discontinue breastfeeding. However, the infant should be monitored for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsants. Maternal serum level monitoring and dosage adjustment is advisable in the early postpartum period if the drug was taken throughout pregnancy and breastfeeding.[1] Some evidence suggests that levetiracetam might reduce the maternal breastmilk supply in some women.

Spritam | Levetiracetam Tablet, For Suspension and breastfeeding

What should I do if already breastfed my kid after using Spritam | Levetiracetam Tablet, For Suspension?

As usage of Spritam | Levetiracetam Tablet, For Suspension is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Spritam | Levetiracetam Tablet, For Suspension else no further action is required.


My health care provider has asked me to use Spritam | Levetiracetam Tablet, For Suspension, what to do?

Usage of Spritam | Levetiracetam Tablet, For Suspension is safe for nursing mothers and baby, No worries.


If I am using Spritam | Levetiracetam Tablet, For Suspension, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Spritam | Levetiracetam Tablet, For Suspension in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Levetiracetam Injection Injection, Solution, Concentrate
Roweepra Xr | Levetiracetam Tablet, Extended Release